pemazyre
incyte biosciences distribution b.v. - pemigatinib - cholangiocarcinoma - antineoplastické činidlá - pemazyre monotherapy is indicated for the treatment of adults with locally advanced or metastatic cholangiocarcinoma with a fibroblast growth factor receptor 2 (fgfr2) fusion or rearrangement that have progressed after at least one prior line of systemic therapy.
sporanox
johnson & johnson, s.r.o., slovensko - itrakonazol - 26 - antimycotica (lokÁlne a celkovÉ)
turalio
daiichi sankyo europe gmbh - pexidartinib - giant cell tumor of tendon sheath; synovitis, pigmented villonodular - antineoplastické činidlá - treatment of tenosynovial giant cell tumour.